Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Medical Center for clinical research
1140
mi
from
San Diego, CA
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Medical Center for clinical research
1140
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
San Francisco Clinical Research Center
1339
mi
from
San Francisco, CA
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
San Francisco Clinical Research Center
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
California Medical Clinic for Headache
1181
mi
from
Santa Monica, CA
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
California Medical Clinic for Headache
1181
mi
from
Santa Monica, CA
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Radiant Research - Denver
403
mi
from
Denver, CO
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Radiant Research - Denver
403
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Florida Clinical Research Center LLC
1138
mi
from
Maitland, FL
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Florida Clinical Research Center LLC
1138
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Accelovance
1193
mi
from
Melbourne, FL
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Accelovance
1193
mi
from
Melbourne, FL
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Renstar Medical Research
1078
mi
from
Ocala, FL
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Renstar Medical Research
1078
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Broward Research Group
1306
mi
from
Pembroke Pines, FL
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Broward Research Group
1306
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Neurology Clinical Research, Inc.
1298
mi
from
Sunrise, FL
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Neurology Clinical Research, Inc.
1298
mi
from
Sunrise, FL
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
MedVadis Research
1437
mi
from
Watertown, MA
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
MedVadis Research
1437
mi
from
Watertown, MA
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Westside Family Medical Center
718
mi
from
Kalamazoo, MI
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Westside Family Medical Center
718
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Ryan Headache Center, St. John's Mercy Medical Group
399
mi
from
Chesterfield, MO
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Ryan Headache Center, St. John's Mercy Medical Group
399
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Clinvest/A Division of Banyan Group, Inc.
251
mi
from
Springfield, MO
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Clinvest/A Division of Banyan Group, Inc.
251
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Prarie Fields Medicine/Clinical Research Advantage
264
mi
from
Fremont, NE
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Prarie Fields Medicine/Clinical Research Advantage
264
mi
from
Fremont, NE
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
James Meli DO Ltd (Clinical Research Advantage)
954
mi
from
Henderson, NV
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
James Meli DO Ltd (Clinical Research Advantage)
954
mi
from
Henderson, NV
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Clinical Research Advantage
954
mi
from
Henderson, NV
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Clinical Research Advantage
954
mi
from
Henderson, NV
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Pharmquest
999
mi
from
Greensboro, NC
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Pharmquest
999
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
PMG Research of Winston-Salem
976
mi
from
Winston-Salem, NC
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
PMG Research of Winston-Salem
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
COR Clinical Research
157
mi
from
Oklahoma City, OK
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
COR Clinical Research
157
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
PMG Research of Bristol, LLC
861
mi
from
Bristol, TN
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
PMG Research of Bristol, LLC
861
mi
from
Bristol, TN
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
ClinSearch, LLC
728
mi
from
Chattanooga, TN
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
ClinSearch, LLC
728
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Neurology Studies of Austin, A Division of DermResearch Inc.
517
mi
from
Austin, TX
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Neurology Studies of Austin, A Division of DermResearch Inc.
517
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
FutureSearch Trials of Neurology and Sleep Lab
517
mi
from
Austin, TX
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
FutureSearch Trials of Neurology and Sleep Lab
517
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
FutureSearch Trials of Dallas
342
mi
from
Dallas, TX
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
FutureSearch Trials of Dallas
342
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Clinical Trial Network (CTN Texas)
569
mi
from
Houston, TX
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Clinical Trial Network (CTN Texas)
569
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated:  2/1/2013
Neurology & Headache Treatment Center
1118
mi
from
Maclean, VA
A Study of LY2951742 in Patients With Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine
Status: Enrolling
Updated: 2/1/2013
Neurology & Headache Treatment Center
1118
mi
from
Maclean, VA
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
683
mi
from
Birmingham, AL
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
853
mi
from
Phoenix, AZ
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
1143
mi
from
San Diego, CA
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
409
mi
from
Denver, CO
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
409
mi
from
Denver, CO
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
1344
mi
from
New Haven, CT
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
1307
mi
from
Fort Lauderdale, FL
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
1307
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
801
mi
from
Atlanta, GA
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
671
mi
from
Anderson, IN
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
671
mi
from
Anderson, IN
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
196
mi
from
Kansas City, KA
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
196
mi
from
Kansas City, KA
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
657
mi
from
Louisville, KY
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
657
mi
from
Louisville, KY
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
697
mi
from
New Orleans, LA
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
1418
mi
from
Ayer, MA
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
1418
mi
from
Ayer, MA
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
841
mi
from
Detroit, MI
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
689
mi
from
Duluth, MN
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
689
mi
from
Duluth, MN
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
418
mi
from
St Louis, MO
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
418
mi
from
St Louis, MO
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
221
mi
from
Grand Island, NE
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
221
mi
from
Grand Island, NE
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
954
mi
from
Henderson, NV
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
954
mi
from
Henderson, NV
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
1291
mi
from
Bronx, NY
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
1291
mi
from
Bronx, NY
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
858
mi
from
Asheville, NC
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
858
mi
from
Asheville, NC
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
645
mi
from
Bismarck, ND
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
645
mi
from
Bismarck, ND
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
898
mi
from
Akron, OH
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
898
mi
from
Akron, OH
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
158
mi
from
Oklahoma City, OK
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated:  2/25/2013
Clinical Research Facility
1209
mi
from
Allentown, PA
Zomig - Treatment of Acute Migraine Headache in Adolescents
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
Status: Enrolling
Updated: 2/25/2013
Clinical Research Facility
1209
mi
from
Allentown, PA
Click here to add this to my saved trials